Get notified of page updates
Glossary on
off
Clinicaltrials.gov identifier:
NCT05112601
Treatment study for people with endometrial cancer that has returned
Testing Immunotherapy Treatments for Recurrent Endometrial Cancer
About the Study
This study is no longer enrolling people.
This study tests the combination of two drugs compared to one drug to shrink tumors in patients with endometrial cancer that has returned after not being detected for a period of time (recurrent). The study is enrolling people with a known as .
This Study is Open To:
This study is no longer enrolling people.
This Study is Not Open To:
This study is no longer enrolling people.